C4 Therapeutics Inc (CCCC)

NASDAQ
37.28
-0.48(-1.27%)
After Hours
37.50
+0.22(+0.59%)
- Real-time Data
  • Volume:
    423,458
  • Bid/Ask:
    34.66/46.88
  • Day's Range:
    36.88 - 38.99

CCCC Overview

Prev. Close
37.28
Day's Range
36.88-38.99
Revenue
40.63M
Open
38.47
52 wk Range
22.4-48.97
EPS
-
Volume
423,458
Market Cap
1.77B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
437,804
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
47,358,960
Next Earnings Date
Sep 01, 2021
What is your sentiment on C4 Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

C4 Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellBuy
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Buy
SummaryStrong BuyNeutralStrong SellStrong SellStrong Buy

C4 Therapeutics Inc Company Profile

C4 Therapeutics Inc Company Profile

Employees
99

C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in preclinical stage targeting IKZF1/3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; and BRAF V600E to treat melanoma, non-small cell lung cancer, colorectal cancer, and other solid malignancies, as well as RET to treat lung cancer, sporadic medullary thyroid cancers, and other solid malignancies. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffman-La Roche Ltd.; Biogen, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.